The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
(Approval lapsed) OZEMPIC semaglutide 0.25mg solution for injection pre-filled pen (Czech Republic)
Section 19A approved medicine
(Approval lapsed) OZEMPIC semaglutide 0.25mg solution for injection pre-filled pen (Czech Republic)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen - ARTG 308324
Indication(s)
OZEMPIC is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:
- as monotherapy when metformin is not tolerated or contraindicated.
- in addition to other medicinal products for the treatment of type 2 diabetes.
Images
